We also did not consider expenditure for drugs used in oncology supportive care, such as agents to control chemotherapy-induced nausea and vomiting, narcotics and other analgesics, and growth factors (e.g. G-CSF), and our data therefore underestimate the real malignancy-related drug expenditure for cancer patients. The gene discussed is CSF3; the disease is cancer.